1 / 32

Care of the Vulnerable Population: Children

Care of the Vulnerable Population: Children. Dr. James Paton Royal Hospital for Sick Children Glasgow. Care of Vulnerable Population - Children. Clinical Presentations Triage and Severity Assessment Recommended treatments – Part 1 Investigations in Hospital

pierce
Download Presentation

Care of the Vulnerable Population: Children

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Care of the Vulnerable Population: Children Dr. James Paton Royal Hospital for Sick Children Glasgow

  2. Care of Vulnerable Population - Children • Clinical Presentations • Triage and Severity Assessment • Recommended treatments – Part 1 • Investigations in Hospital • Recommended treatments – Part 2 • Ethics & Staffing during a pandemic

  3. Fleming, D M et al. Arch Dis Child 2005;90:741-746

  4. Clinical Characteristics of RSV and ‘Flu in Hospitalised Children Meury et al Eur J Pediatr 2004; 163:359-363

  5. Timing of 153 Cases of Fatal Influenza in Children - United States, 2003-2004 Season Timing of 153 Cases of Fatal Influenza in Children – US 2003-04 Bhat, N. et al. N Engl J Med 2005;353:2559-2567

  6. Timing of 153 Cases of Fatal Influenza in Children - United States, 2003-2004 Season Whose at Risk? • Impact of Age • Impact of pre-existing medical conditions

  7. 'Flu Mortality Rate According to Age Group – US 2003-04 Bhat, N. et al. N Engl J Med 2005;353:2559-2567

  8. Relative Risk of Admission in Children without High Risk Conditions Izurieta H et al. N Engl J Med 2000;342:232-239

  9. Underlying Health Status in Children with Fatal Influenza – US 2003-04 (n- 149) Bhat, N. et al. N Engl J Med 2005;353:2559-2567

  10. Triage and General Management in 1ry Care • Recognition of ‘At Risk Groups’ • Assessment of Illness Severity • Current advice and guidance on epidemiology of pandemic

  11. Severity Assessment (CURB 65) in Adults

  12. Respiratory Distress – Severity Assessment in Children Appendix 8 Thorax 2007;62: Supplement 1

  13. Severity Assessment in Children

  14. Triage & General Management in 1ry Care Thorax 2007;62:Supplement 1

  15. Specific Treatment - Anti-Viral Therapy • Amantidine / rimantidine • Neuraminidase inhibitors • Oseltamivir (Tabs & liquid) • Effective if given within 2 days of start of illness • Reduction in time to alleviation of symptoms • Reduction in complications requiring antibiotics • Note - faster drug clearance in younger children • Not licensed under 1 year - but Japanese experience suggests is safe • Zanamavir (inhaler – so children >5yrs) • Ribavirin

  16. Triage of Children in Hospital • Assessment of Illness severity • Admit to ward if: • Severe respiratory distress; Hypoxia • Severe dehydration • Altered conscious level or prolonged seizure • Signs of septicaemia • Consider HDU/ICU • Worsening hypoxia despite oxygen • Worsening respiratory failure • Apnoea or slow/irregular breathing • Encephalopathy • If no ICU Beds?

  17. Investigations for Children in Hospital • Pulse oximetry • CXR • if hypoxic or severely ill, or deteriorating; Not routinely • FBC, U & Es, LFTs, Blood Culture • Microbiology

  18. Microbiological Investigations for Children in Hospital Early Pandemic – when you want to know • Virology • NPA for Respiratory panel - ‘flu A & B; RSV, Adeno, Rhino, Paraflu 1,2,3 • Rapid influenza tests – high specificity - R/I ‘flu • Acute & Convalescent Serum • Bacteriology • Blood • Sputum Established Pandemic – when you know • Virology – not routine • Bacteriology

  19. Anti-Viral Therapy in Hospital • Neuraminidase inhibitors • Oseltamivir (Tabs & liquid) • If severely ill with symptoms for <6 days • Child <1year with severe infection with informed consent

  20. Antibioticsfor Children in Hospital • Secondary bacterial infections are common • Pneumonia • Otitis media

  21. Pneumococcal Pneumonia in Previously Healthy Children O’Brien et al. Clin Infect Dis 2000;30:784-9

  22. Bacterial Co-infections in 24 Children with Fatal Influenza Bhat, N. et al. N Engl J Med 2005;353:2559-2567

  23. Activation-associated Cell Death of Bone Marrow GRC during LCMV infection Navarini, Alexander A. et al. (2006) Proc. Natl. Acad. Sci. USA 2006; 103: 15535-15539 Early phase of infection largely controlled by innate resistance via granulocytes. Virus-induced suppression of antibacterial resistance and immunity by IFN 1 production was caused by apoptosis of bone marrow granulocytes and impaired granulocyte emigration. Granulocytopenia was not complete but became functionally limiting during super-infection when large numbers of granulocytes were rapidly required to control infection

  24. Antibiotics for Children in Hospital • Children at risk of complications • Children with disease severe enough to be admitted Treat prophylactically with antibiotic to cover • Staph aureus • Str pneumoniae • H influenzae = Co-amoxiclav; Or clarithromycin, cefuroxime if pen. allergic

  25. Will There be Sufficient Staff?

  26. Professional Duty – Family or Patient First? Ehrenstein et al BMC Public Health 2006;6:311

  27. The Next Influenza Pandemic: Will be Ready to Care for Our Children? “The severity of the 2003-2004 'flu season will pale in comparison with that of the next pandemic” Woods and Abramson J Pediatr 2005;147:147-155

More Related